Endocrine profile of a nonsteroidal antiandrogen N-(3,5-dimethyl-4-isoxazolylmethyl)phthalimide (DIMP).
D015068:17-Ketosteroids / Q000037:antagonists & inhibitors; D000726:Androgen Antagonists; D000736:Androstenes / Q000037:antagonists & inhibitors; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D002369:Castration; D003864:Depression, Chemical; D013196:Dihydrotestosterone / Q000037:antagonists & inhibitors; D005260:Female; D005474:Fluoxymesterone / Q000037:antagonists & inhibitors; D007094:Imides / Q000494:pharmacology*; D008297:Male; D009929:Organ Size; D010080:Oxazoles / Q000494:pharmacology; D010795:Phthalic Acids / Q000494:pharmacology*; D010797:Phthalimides; D011467:Prostate / Q000187:drug effects*; D051381:Rats; D012669:Seminal Vesicles / Q000187:drug effects*; D013737:Testis / Q000187:drug effects* / Q000502:physiology; D013739:Testosterone / Q000037:antagonists & inhibitors; D014599:Uterus / Q000187:drug effects*
D015068:17-Ketosteroids; D000726:Androgen Antagonists; D000736:Androstenes; D007094:Imides; D010080:Oxazoles; D010795:Phthalic Acids; D010797:Phthalimides; D013196:Dihydrotestosterone; C002631:N-(3,5-dimethyl-4-isoxazolylmethyl)phthalimide; D013739:Testosterone; D005474:Fluoxymesterone